Insider Trading activities of Kos Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Kos Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Kos Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Kos Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is KOSP. The reporting company's CIK number is 1018952.
The total value of stock buying since 2005 is $0.
The total value of stock sales since 2005 is $12,258,425.
The total value of stock option exercises since 2005 is $1,890,841.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Kos Pharmaceuticals Inc (KOSP).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2006-11 0 $0 12,500 $961,875 12,500 $444,750
2006-03 0 $0 65,750 $3,191,081 65,750 $1,348,591
2006-02 0 $0 5,000 $250,000 5,000 $97,500
2005-12 0 $0 39,800 $2,822,301 0 $0
2005-08 0 $0 22,327 $1,583,509 0 $0
2005-07 0 $0 8,309 $622,875 0 $0
2005-06 0 $0 10,766 $681,591 0 $0
2005-05 0 $0 7,150 $383,433 0 $0
2005-04 0 $0 35,750 $1,761,760 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Kos Pharmaceuticals Inc insiders (KOSP)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2006-11-06 Rosskamp Ralf (EVP, Research and Development) Sale 12,500 76.95 961,875
2006-11-06 Rosskamp Ralf (EVP, Research and Development) Option Ex 12,500 35.58 444,750
2006-03-16 Rodriguez Juan F (SVP, Controller & Corp. Admin.) Sale 7,000 50.80 355,600
2006-03-16 Rodriguez Juan F (SVP, Controller & Corp. Admin.) Option Ex 7,000 16.24 113,645
2006-03-14 Baldini Robert E (Director) Sale 7,500 48.80 366,000
2006-03-14 Baldini Robert E (Director) Option Ex 7,500 22.55 169,125
2006-03-13 Baldini Robert E (Director) Sale 2,500 49.40 123,500
2006-03-13 Baldini Robert E (Director) Option Ex 2,500 22.55 56,375
2006-03-13 Mcgovern Mark E (EVP, Chief Medical Officer) Sale 28,750 49.00 1,408,750
2006-03-13 Mcgovern Mark E (EVP, Chief Medical Officer) Option Ex 28,750 21.02 604,468
2006-03-10 King Richard (EVP, Commercial Operations) Sale 5,000 50.00 250,000
2006-03-10 King Richard (EVP, Commercial Operations) Option Ex 5,000 19.50 97,500
2006-03-09 Baldini Robert E (Director) Sale 2,500 47.50 118,750
2006-03-07 Baldini Robert E (Director) Sale 7,322 45.81 335,420
2006-03-07 Baldini Robert E (Director) Option Ex 9,822 21.02 206,507
2006-03-06 Baldini Robert E (Director) Sale 5,178 45.01 233,061
2006-03-06 Baldini Robert E (Director) Option Ex 5,178 19.50 100,971
2006-02-16 King Richard (EVP, Commercial Operations) Sale 5,000 50.00 250,000
2006-02-16 King Richard (EVP, Commercial Operations) Option Ex 5,000 19.50 97,500
2005-12-14 Whittemore Frederick B (Director) Sale 17,600 70.48 1,240,377
2005-12-08 Whittemore Frederick B (Director) Sale 18,000 71.31 1,281,545
2005-08-16 Adams Adrian (CEO) Sale 13,818 70.87 979,452
2005-08-01 King Richard (EVP, Commerical Oper) Sale 3,000 71.34 214,020
2005-07-19 Adams Adrian (CEO) Sale 8,309 74.96 622,875
2005-06-21 Adams Adrian (CEO) Sale 7,150 66.18 473,201
2005-06-14 Baldini Robert E (Director) Sale 3,616 57.63 208,390
2005-05-17 Adams Adrian (CEO) Sale 7,150 53.63 383,433
2005-04-19 Adams Adrian (CEO) Sale 35,750 49.28 1,761,760

Insider trading activities including stock purchases, stock sales, and option exercises of KOSP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Kos Pharmaceuticals Inc (symbol KOSP, CIK number 1018952) see the Securities and Exchange Commission (SEC) website.